Sökning: onr:"swepub:oai:lup.lub.lu.se:a103c3ae-8efd-49b4-b46e-00911b9ecff8" > Exome sequencing of...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03992naa a2200409 4500 | |
001 | oai:lup.lub.lu.se:a103c3ae-8efd-49b4-b46e-00911b9ecff8 | |
003 | SwePub | |
008 | 190618s2019 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/a103c3ae-8efd-49b4-b46e-00911b9ecff82 URI |
024 | 7 | a https://doi.org/10.1038/s41586-019-1231-22 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Flannick, Jasonu Harvard University,Broad Institute,Boston Children's Hospital4 aut |
245 | 1 0 | a Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls |
264 | c 2019-05-22 | |
264 | 1 | b Springer Science and Business Media LLC,c 2019 |
300 | a 6 s. | |
520 | a Protein-coding genetic variants that strongly affect disease risk can yield relevant clues to disease pathogenesis. Here we report exome-sequencing analyses of 20,791 individuals with type 2 diabetes (T2D) and 24,440 non-diabetic control participants from 5 ancestries. We identify gene-level associations of rare variants (with minor allele frequencies of less than 0.5%) in 4 genes at exome-wide significance, including a series of more than 30 SLC30A8 alleles that conveys protection against T2D, and in 12 gene sets, including those corresponding to T2D drug targets (P = 6.1 × 10−3) and candidate genes from knockout mice (P = 5.2 × 10−3). Within our study, the strongest T2D gene-level signals for rare variants explain at most 25% of the heritability of the strongest common single-variant signals, and the gene-level effect sizes of the rare variants that we observed in established T2D drug targets will require 75,000–185,000 sequenced cases to achieve exome-wide significance. We propose a method to interpret these modest rare-variant associations and to incorporate these associations into future target or gene prioritization efforts. © 2019, The Author(s), under exclusive licence to Springer Nature Limited. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Medicinsk genetik0 (SwePub)301072 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Medical Genetics0 (SwePub)301072 hsv//eng |
653 | a Mus | |
700 | 1 | a Lyssenko, Valeriyau Lund University,Lunds universitet,Genomik, diabetes och endokrinologi,Forskargrupper vid Lunds universitet,Genomics, Diabetes and Endocrinology,Lund University Research Groups,University of Bergen4 aut0 (Swepub:lu)endo-vly |
700 | 1 | a Groop, Leifu Lund University,Lunds universitet,Genomik, diabetes och endokrinologi,Forskargrupper vid Lunds universitet,Genomics, Diabetes and Endocrinology,Lund University Research Groups4 aut0 (Swepub:lu)endo-lgr |
700 | 1 | a Nilsson, Peteru Lund University,Lunds universitet,Enheten för medicinens historia,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,History of Medicine,Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Internal Medicine - Epidemiology,Lund University Research Groups4 aut0 (Swepub:lu)medf-pni |
700 | 1 | a Boehnke, Michaelu University of Michigan4 aut |
710 | 2 | a Harvard Universityb Broad Institute4 org |
710 | 2 | a DiscovEHR Collaboration |
773 | 0 | t Natured : Springer Science and Business Media LLCg 570:7759, s. 71-76q 570:7759<71-76x 0028-0836x 1476-4687 |
856 | 4 | u http://dx.doi.org/10.1038/s41586-019-1231-2x freey FULLTEXT |
856 | 4 | u https://www.nature.com/articles/s41586-019-1231-2.pdf |
856 | 4 8 | u https://lup.lub.lu.se/record/a103c3ae-8efd-49b4-b46e-00911b9ecff8 |
856 | 4 8 | u https://doi.org/10.1038/s41586-019-1231-2 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy